RPG Life Sciences Limited | RPGLIFE | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 16 | 9 | 8 | 11 | 408 |
Short-term investment |
| 0 | 0 | 0 | 0 | 0 |
Accounts receivables |
| 396 | 681 | 389 | 633 | 574 |
Inventories |
| 458 | 537 | 410 | 466 | 583 |
Deferred income taxes |
| 0 | 0 | 0 | 19 | 0 |
Other current assets |
| 100 | 199 | 164 | 147 | 194 |
Total current assets |
| 970 | 1,426 | 971 | 1,277 | 1,759 |
Gross property plant... |
| 822 | 799 | 825 | 837 | 785 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 822 | 799 | 825 | 837 | 785 |
Work in Progress |
| 18 | 48 | 101 | 73 | 94 |
Miscellaneous Investment |
| 107 | 4 | 17 | 5 | 5 |
Deferred income taxes |
| 0 | 80 | 62 | 46 | 13 |
Intangible assets |
| 545 | 548 | 522 | 419 | 371 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 0 | 7 | 15 | 11 | 7 |
Total non-current assets |
| 1,492 | 1,487 | 1,542 | 1,391 | 1,275 |
Total assets |
| 2,463 | 2,913 | 2,512 | 2,667 | 3,034 |
Short-term debt |
| 240 | 379 | 290 | 51 | 5 |
Accounts Payable... |
| 287 | 519 | 251 | 444 | 474 |
Provisions |
| 11 | 123 | 103 | 128 | 136 |
Taxes Payable |
| 0 | 2 | 0 | 0 | 0 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
| 149 | 185 | 133 | 203 | 181 |
Total current liabilities |
| 687 | 1,207 | 778 | 826 | 797 |
Long-term debt |
| 162 | 102 | 66 | 15 | 7 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 22 | 0 | 0 | 0 | 0 |
Provisions |
| 23 | 28 | 34 | 27 | 31 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 28 | 28 | 30 | 33 | 34 |
Total non-current liabilities |
| 235 | 158 | 129 | 76 | 73 |
Total liabilities |
| 922 | 1,365 | 907 | 902 | 869 |
Share Capital |
| 132 | 132 | 132 | 132 | 132 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 1,409 | 1,415 | 1,473 | 1,633 | 2,032 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 1,541 | 1,548 | 1,605 | 1,766 | 2,165 |
Total Liabilities and Equity |
| 2,463 | 2,913 | 2,512 | 2,667 | 3,034 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |